GoodRx Tirzepatide Review: A Discount Card, Not a Prescriber (2026)

GoodRx is fundamentally different from every other entry on this site: it's a prescription discount card, not a telehealth platform or a prescriber. It offers genuine, well-below-retail cash prices on brand-name Zepbound and Foundayo (orforglipron) at 70,000+ pharmacies nationwide — but you need a prescription from a clinician elsewhere before GoodRx's discount does anything for you. This review's original attempt to independently verify current pricing directly against goodrx.com was blocked by a PerimeterX bot-detection challenge (CAPTCHA), so figures below are.

Updated August 11, 2026 — the live price check has now been done. goodrx.com was reachable on a fresh attempt and we priced Zepbound across every dose, both device formats and two ZIP codes. The $299 figure held, with one correction that matters: it is Eli Lilly's own manufacturer offer displayed on GoodRx, not a rate GoodRx negotiated, and GoodRx's own coupon for the single-dose pen format was $995. The full working, with the conditions attached to each number, is in what GoodRx actually costs for Zepbound. This page answers what GoodRx is; that one answers what it charges.

What GoodRx actually is

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform — not a telehealth provider, not a compounding pharmacy, and not a prescriber. You bring your own prescription and present GoodRx's discount card at the pharmacy counter; no membership fee is required.

What GoodRx's discount is worth

Self-pay through GoodRx runs $299/month for brand Zepbound KwikPen — well under Eli Lilly's typical cash list price — and $149/month for brand Foundayo (orforglipron), matching the lowest cash price seen at launch. Both figures apply to brand-name, FDA-approved medication, not compounded product. Higher doses of either drug may cost more than the headline figure.

Real reach — 70,000+ pharmacies

GoodRx is honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1-adjacent channel this site has reviewed. Pricing can shift as Lilly's manufacturer coupon program evolves, so confirm the current rate at checkout.

The brand-vs-compounded question — doesn't apply here

This is the one review on this site where the brand-vs-compounded framing isn't the central question: GoodRx only discounts brand-name, FDA-approved medication — Zepbound, Mounjaro, and now Foundayo — never compounded product. If you're comparing GoodRx to the compounded providers elsewhere on this site, you're comparing two structurally different things: a discount on the approved drug itself, versus a pharmacy-made alternative. See our Zepbound cost and savings guide for how GoodRx's rate stacks up against LillyDirect and other brand-access routes.

How this fits into your GLP-1 shopping

GoodRx's real value: genuine, checkable savings on brand-name FDA-approved medication, a massive pharmacy network, and no membership fee — you only need it at the counter. The trade-off, structurally: it's not a prescriber — you still need a clinician visit to get the prescription GoodRx then discounts, it's self-pay only and doesn't apply toward insurance deductibles, and pricing can shift with the manufacturer's own coupon program. As with any brand-name access route, compare GoodRx's rate against LillyDirect's own self-pay price and your insurance's covered rate before committing to any one channel; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

GoodRx isn't a competitor to the compounded telehealth providers on this site — it's a genuine, checkable discount tool for anyone who already has (or can get) a brand-name Zepbound or Foundayo prescription. If you value the FDA-approved product and can find a prescriber, comparing GoodRx's $299/month against LillyDirect's own self-pay rate in our Zepbound cost and savings guide is the right next step. Another provider that leads with genuine brand access rather than compounded product is Heally, worth comparing directly. So does Klinic, which also accepts insurance directly, and so does Levity, a brand-only, no-compounded-fallback provider. See our best tirzepatide providers ranking for the compounded telehealth alternatives.